Tuesday, March 28, 2017 9:49:16 AM
Re: None
Post # of 18142
VDRM MUCH HIGHER $1.50 to $5.00 NEAR TERM
my analysis tells me that we might be headed higher alot higher starting very soon ( possibly this week )...
1) the technical are showing a perfect triangle pattern with a moving average about to swing to a huge buy signal, with .20 in site as high a while back that is the target to start
2) now lets get to the rub of it, the last time VDRM ran it ran to $5.00 with 75m shares outstanding giving it a 350m cap; so lets fast forward now and $1.50 is the target here
3) the only competition sells the somewhat equivalent that take much longer to work at $500 a bottle vs VDRM $40 (avg)...in a market of 2.4b in the USA alone they will own the marketplace and with international brace yourself
4) with the pipeline of a potential TOPICAL viagra on top of TOENAIL FUNGUS for DIABETICS that alone is worth taking them out as they will be the disruptor in the marketplace and a target of $5.00 or 1b is reachable.
5) now break into the sales and earnings of on average a biotech and medical company of at least 3x - 5x and a run to a $10.00 level is quite attainable
so lets sum up:
.25 to .75 near term
1.50 target ( for inst'l and research and brokerage support with mutual funds )
5.00 target at 3x the baseline
10.00 expanded target once the street fully appreciates them and hospitals start using there product USA wide with the reduction of Obama care and the need to cut costs fro 500 to 40 or 85% discount!!
this is a pure play on licensing and that my friends is where it starts and ends...
MY OPINIONS ARE MY OWN PLEASE DO YOUR OWN DD
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM